Back to Journals » Drug Design, Development and Therapy » Volume 16
RETRACTED ARTICLE: Preparation, in vitro and in vivo Evaluation of Thermosensitive in situ Gel Loaded with Ibuprofen-Solid Lipid Nanoparticles for Rectal Delivery
Authors Huang CH , Hu PY , Wu QY, Xia MY, Zhang WL, Lei ZQ, Li DX, Zhang GS, Feng JF
Received 24 December 2021
Accepted for publication 27 April 2022
Published 12 May 2022 Volume 2022:16 Pages 1407—1431
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Tin Wui Wong
This paper has been retracted.
Huang CH, Hu PY, Wu QY, et al. Drug Des Devel Ther. 2022;16:1407‒1431.
The Editor and Publisher of Drug Design, Development and Therapy wish to retract the published article. Concerns were raised regarding the alleged duplication of images for Figure 6C and 6D, despite both images being described as separate experimental conditions.
The authors responded to our queries but were unable to provide a satisfactory explanation for the alleged image duplication, nor were they able to provide adequate original data that would verify the reported findings. The Editor requested to retract the article and the authors were notified of this.
We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.